- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03861117
Pressure Support and Positive End Expiratory Pressure During Spontaneous Breathing Trial (SBT-ICU)
February 27, 2024 updated by: Hospices Civils de Lyon
Impact of the Combination of Pressure Support and Positive End Expiratory Pressure During Spontaneous Breathing Trial Versus T-piece on the Time to Successful Extubation
The aim of this study is to assess if a bundle associating pressure support and positive end-expiratory pressure during spontaneous breathing trial and detection by T-piece of patients with high-risk of extubation failure can reduce the time to successful extubation in critically ill patients.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
98
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mehdi MEZIDI, MD, PhD
- Phone Number: +33 04.26.10.92.64
- Email: mezidi.mehdi@chu-lyon.fr
Study Locations
-
-
-
Lyon, France, 69317
- Hopital de la Croix-Rousse
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patient 18 years old or more
- Intubated and ventilated in intensive care unit for more than 24 hours
- Patient ready for weaning evaluation
- Failure of a first T-piece SBT
Exclusion Criteria:
- Chronic neuromuscular disease
- Guillain-Barré Syndrome
- Central nervous system disease with consciousness disorder
- Tracheostomy
- Chronic disease with life expectancy less than 1 year
- Pregnancy, breast feeding
- Withholding life support regarding a reintubation
- Prisoner or patient interned in psychiatric hospital
- Guardianship
- Language barrier
- Lack of medical insurance
- Lack of the patient's consent (or of the next of kin where appropriate)
- Patient under an exclusion period after enrollment in another research study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Assisted strategy
Ability to be weaned is determined with pressure support and positive end-expiratory pressure.
|
Daily spontaneous breathing trial (SBT) with 7 cmH2O pressure support and 5 cmH2O positive end-expiratory pressure are performed to assess weanability.
In case of success, a SBT with T-piece is performed to determine if the patients is at high risk of extubation failure.
In this case and/or in the presence of risk factors, systematic non-invasive ventilation is applied after extubation.
|
Active Comparator: Non assisted strategy
Ability to be weaned is determined with T-piece.
|
Daily spontaneous breathing trials (SBT) with T-piece are performed to assess weanability.
In the presence of risk factors, systematic non-invasive ventilation is applied after extubation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time (hours) to successful extubation
Time Frame: 90 days
|
Successful extubation is defined as extubation without retintubation within the 7 following days.
|
90 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of first extubation
Time Frame: 90 days
|
percentage (%) of patients with a first successful extubation divided by the total number of patients per group
|
90 days
|
Invasive mechanical ventilation duration
Time Frame: 90 days
|
time (hours) spent on invasive mechanical ventilation since inclusion
|
90 days
|
duration of non-invasive and invasive mechanical ventilation
Time Frame: 90 days
|
time (hours) spent on invasive or non mechanical ventilation since inclusion
|
90 days
|
ventilator-free days at Day 90
Time Frame: 90 days
|
90 minus the number of days spent on invasive mechanical ventilation (days) since inclusion.
Zero day is allocated to dead patients.
|
90 days
|
Intensive care unit length of stay
Time Frame: 90 days
|
time (days) spent in intensive care unit from inclusion until discharge or death
|
90 days
|
hospital length of stay
Time Frame: 90 days
|
time (days) spent in the hospital from inclusion until discharge or death
|
90 days
|
Day 90 mortality
Time Frame: 90 days
|
percentage (%) of patients dead at Day 90
|
90 days
|
reintubation rate
Time Frame: 90 days
|
percentage (%) of the number of patients with any reintubation divided by the number of patients per group
|
90 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 10, 2019
Primary Completion (Actual)
June 1, 2023
Study Completion (Actual)
June 1, 2023
Study Registration Dates
First Submitted
March 1, 2019
First Submitted That Met QC Criteria
March 1, 2019
First Posted (Actual)
March 4, 2019
Study Record Updates
Last Update Posted (Actual)
February 28, 2024
Last Update Submitted That Met QC Criteria
February 27, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 69HCL18_0982
- 2019-A00106-51 (Other Identifier: ID-RCB)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critically Ill Adult Patients With Difficult Weaning
-
Prince of Songkla UniversityUnknown
-
KU LeuvenCompletedCritically Ill Patients With a Predicted Prolonged ICU StayBelgium
-
University Hospital, RouenCompletedSedated Patients | Critically Ill Patients Under Mechanical VentilationFrance
-
The Cleveland ClinicCompletedCritically Ill Patients | Cardiovascular Surgery Telemetry PatientsUnited States
-
Hospital Sao DomingosCompletedCritically Ill PatientsBrazil
-
University of ZurichIntuitive SurgicalUnknown
-
Policlinico HospitalCompletedCritically Ill PatientsItaly
-
Wuhan Union Hospital, ChinaRecruiting
-
Hospital Sao DomingosCompletedCritically Ill PatientsBrazil
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenCompletedCritically Ill PatientsBelgium
Clinical Trials on Assisted strategy
-
Niguarda HospitalAssociazione Nazionale Medici Cardiologi Ospedalieri; National Centre for Disease...Terminated
-
Ajou University School of MedicineCompletedBiliary Tract Diseases | Bile Duct Neoplasms | Choledocholithiasis | Roux-en-Y AnastomosisKorea, Republic of
-
Hospices Civils de LyonNot yet recruiting
-
China National Center for Cardiovascular DiseasesUnknown
-
Centre Hospitalier Universitaire de NīmesCompletedCentral Venous CatheterizationFrance
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceCompleted
-
Yale UniversityNational Institute of Allergy and Infectious Diseases (NIAID); National Heart...CompletedTuberculosis | Tuberculosis, PulmonaryUganda
-
Alliance for International Medical ActionHarvard School of Public Health (HSPH); University of Bordeaux, INSERM, Bordeaux...CompletedAcute Malnutrition in Infancy (Disorder)Niger
-
Medical University of South CarolinaCompleted
-
University Hospital, AngersRecruitingPhysical Activity | AgedFrance